The SIU 2017 Spring Term educational programme aims to guide participants through many of the key practical skills required to take an idea from laboratory research and published work to a fully formed and translatable business idea. The talks will cover subjects such as; combining roles in academia and biotech; analysing, fine tuning and executing your plan for a biotech business; patenting your research to add value and defensibility to your business; and insights into how to attract the big science funders.



In this session participants will learn how to act on your great idea and build your business. Participants will leave knowing where to start and how to establish your first steps towards success. Crucial steps such as selection of a team, investigation of the potential associated risks and critical analysis of your business model will be covered.


GUEST SPEAKER: Dr. Simon bennetT 

John Hanbury Lecture Theatre | UCL School of Pharmacy - (6.30pm to 8pm)

Dr. Simon Bennett is an independent consultant with over 20 years of biotech industry experience. He mentors and advises early-stage businesses and management teams, and has senior management experience from start-up through to IPO and trade sale. Simon currently manages the portfolios of around 10 companies and is board director of MitoDys Therapeutics and colwiz.


GUEST SPEAKER: Alessandro Allegra

Room 802, UCL IOE (Institute of Education), 20 Bedford Way, WC1H 0AL - (6.30pm to 8pm)

After graduating in History and Philosophy of Science from the London School of Economics, Alessandro has worked in UK and international science policy at the UN Educational, Scientific and Cultural Organisation (UNESCO), the Royal Society, and the Royal Society of Biology.

Alessandro is currently pursuing doctoral research at UCL on the use of scientific evidence in policymaking, and collaborates with national and international science policy organisations on a number of projects. He is a board member and Secretary of Association of Italian Scientists in UK (AIS-UK).


Session 2 (02/03/17): using your bioscience skills to impact policy decisions

This talk will focus on using your knowledge in research to the advantage of the public by affecting policies. Particularly, the focus will be on what skills you have achieved in your bioscience studies that are required by governments to help them implement policies. Attendees will thus explore the possible career options available in policy making, and how research is often used in the process of policy making in order to form them with a knowledge and evidence based background

Guest Speaker: PROF. HANS STAUsS

chandler house, 2 Wakefield Street, London WC1N 1PF - (6.00pm to 8pm)

Professor Hans Stauss, Director, Institute of Immunity and Transplantation, UCL.

Professor Hans Stauss was an early trail blazer in the field of cancer immunotherapy demonstrating how modified T cells could be used to effectively target tumours. Recognising the medical potential of this research Hans was involved in setting up Cell Medica which is now advancing an impressive pallet of innovative proprietary technologies in the field of immune cell therapy for cancer and viral infections. Meanwhile Hans continues to turn out cutting edge research and is involved in a number of clinical trials.

Session 3 (13/03/17): Academia and biotech: the entrepreneurial scientist

In this talk participants will learn how they can spin out their research into a biotech company without having to leave their academic research behind. 


In biotech, like in many sectors, patents are used to increase the potential return of an investment, defend an idea from competitors and bring benefit to a business. In the final session of the Spring 2017 series, our speaker will introduce what an IP is, how to obtain them, and how businesses in the biotech sphere can use them to maximum effect.


CHandler house, 2 Wakefield Street, London WC1N 1PF (6.30pm to 8pm)

Dr. Lucy Williams, European Patent Attorney, J A Kemp

After obtaining her PhD in developmental biology from University of Cambridge, Lucy decided to become a patent attorney. She chose J A Kemp because of the size and diversity of the firm itself and its Biotechnology and Life Sciences Group.  

As a patent attorney Lucy has a variety of roles. Some of her responsibilities include acting as an intermediary between clients and patent examiners, patent prosecution and drafting new applications and oppositions.


Guest Speaker: Dr Jeff Skinner

Lecture Theatre 1, London Business School, NW1 4SA (6:30 PM to 9:30 pm)

Jeff Skinner is Director of the Institute of Innovation and Entrepreneurship at London Business School. He actively mentors, encourages and teaches dozens of aspiring entrepreneur MBA students each year. The rest of his time is spent elsewhere in Europe working with scientists who yearn to commercialise their technology and training the technology transfer managers who guide them. Prior to this he was Commercial Director at UCL where he built and ran the spin-out, licensing, R&D collaboration and consultancy units. He holds a PhD from UCL and a MBA from LBS.



How a Bad Commercial Strategy Can Kill a Great Technology (16/11/17)

As a researcher, what does it mean to develop a commercial strategy and if the underlying technology is great (so compelling that it sells itself) do you really need one? We will discuss the ‘sad’ case of a researcher who put his all into commercialising a new technology but who - after burning through his cash had sales that ‘approximated to zero’. We are going to ask whether it was the technology, the market need or his commercial strategy that was to blame. And what he should do next. Along the way we will decompose the elements of a commercial strategy so that you can apply the same framework to yours.

Participants will be emailed some short pre-workshop material to read over 1 week in advance. Please look over this to ensure you are ready to get the most from the workshop.